IMPL - Impel Pharmaceuticals Inc
Close
0.2411
-0.173 -71.796%
Share volume: 858,521
Last Updated: Fri 15 Dec 2023 10:00:01 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.41
-0.17
-41.79%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-16 | 2022-08-15 | 2022-11-14 | 2023-03-27 | 2023-05-12 | 2023-08-18 | 2023-11-14 | |
| Cash flow financing | 65.844 M | -3.036 M | 4.732 M | -79.000 K | 0.000 | 5.000 K | 7.060 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -24.211 M | -28.767 M | -22.678 M | -17.986 M | -24.143 M | -20.440 M | -16.524 M | |
| Net income | -26.970 M | -25.204 M | -31.097 M | -23.041 M | -30.067 M | -7.357 M | -13.814 M | |
| Depreciation | 310.000 K | 289.000 K | 296.000 K | 306.000 K | 272.000 K | -57.000 K | 635.000 K | |
| Changes in inventories | 5.496 M | 6.929 M | 8.622 M | 8.427 M | 8.014 M | 6.985 M | 6.864 M | |
| Changes in receivables | 3.886 M | 4.794 M | 6.129 M | 7.444 M | 6.280 M | 6.801 M | 6.586 M | |
| Investing Cashflow | -8.000 K | -207.000 K | -150.000 K | -1.012 M | -1.046 M | 132.000 K | -957.000 K | |
| Net Borrowings | -34.302 M | -1.549 M | 24.194 M | 50.174 M | 82.188 M | 89.571 M | 109.323 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -8.000 K | -207.000 K | -150.000 K | -1.012 M | -1.046 M | 132.000 K | -957.000 K | |
| Cash Change | 129.837 M | 97.827 M | 79.731 M | 60.654 M | 35.465 M | 15.162 M | 239.000 K |